A caspase inhibitor decreases oxidized low-density lipoprotein- induced apoptosis in bovine endothelial cells

Journal of Surgical Research

Volumn 85, Issue 2, 1999, Pages 323-330

  Farber, Alik ^a   Kitzmiller, Tamar ^a   Morganelli, Peter M ^b   Pfeiffer, Jason ^b   Groveman, Debra ^b   Wagner, Robert J ^a   Cronenwett, Jack L ^a   Powell, Richard J ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CATTLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; FLOW CYTOMETRY; NONHUMAN; PRIORITY JOURNAL;

EID: 0032804213     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5663     Document Type: Article

References (30)

1. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:1993;801.
2. Witztum J. L. The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793.
3. Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation. 95:1997;1062.
4. Hamilton C. A. Low-density lipoprotein and oxidized low-density lipoprotein: Their role in the development of atherosclerosis. Pharmacol. Ther. 74:1997;55.
5. Witztum J. L. Role of oxidized low density lipoprotein in atherogenesis. Br. Heart J. 69:1993;S12.
6. Quinn M. T., Parthasarathy S., Steinberg D. Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc. Natl. Acad. Sci. USA. 82:1985;5949.
7. Cushing S. D., Berliner J. A., Valente A. J. Minimally modified low density lipoprotein induces monocyte chemotactic protein (MCP-1) in human endothelial and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87:1990;5134.
8. Mitchinson M. J., Hardwick S. J., Bennett M. R. Cell death in atherosclerotic plaques. Current Opin. Lipidol. 7:1996;324.
9. Sevanian A., Berliner J., Petterson H. Uptake, metabolism, and cytotoxicity of isomeric cholesterol-5,6-epoxides in rabbit aortic endothelial cells. J. Lipid Res. 32:1991;147.
10. Majno G., Joris I. Apoptosis, oncosis, and necrosis: An overview of cell death. Am. J. Pathol. 146:1995;3.
11. Vaux D. L., Strasser A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;2239.
12. Miller D. K. The role of caspase family of endoproteases in apoptosis. Sem. Immunol. 9:1997;35.
13. Thornberry N. A., Peterson E. P., Zhao J. J. Inactivation of IL-1β converting enzyme by peptide(acyloxy)methylketones. Biochemistry. 33:1994;3934.
14. Peterson G. L. A simplification of the protein assay method of Lowry et al which is more generally applicable. Anal. Biochem. 83:1977;346.
15. Steinbrecher U. P., Parthasarathy S., Leake D. S. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:1984;3883.
16. Morgan J., Leake D. S. Oxidation of low density lipoprotein by iron and copper at acidic pH. J. Lipid Res. 36:1995;2504.
17. Puhl H., Waeg G., Esterbauer H. Methods to determine oxidation of low density lipoproteins. Methods Enzymol. 233:1994;425.
18. Darzynkiewicz Z., Juan G., Li X. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis). Cytometry. 27:1997;1.
19. Koopman G., Reutelingsperger C. P. M., Kuijten G. A. M. Annexin V for flow cytometric detection of phosphatidylserine expression of B cells undergoing apoptosis. Blood. 84:1994;1415.
20. Gavrielli Y., Sherman Y., ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmnetation. J. Cell. Biol. 119:1992;493.
21. Gorczyca W., Gong J., Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 52:1993;1945.
22. Cathcart M. K., Morel D. W., Chisolm G. M. III. Monocytes and neutrophils oxidize low density lipoproteins making it cytotoxic. J. Leukyte Biol. 38:1985;341.
23. Dousset N., Negre-Salvayre A., Lopez M. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells: Chemical modifications of ultraviolet treated low density lipoproteins. Biochem. Biophys. Acta. 1045:1990;219.
24. Geng Y.-J., Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin 1β converting enzyme. Am. J. Pathol. 147:1995;251.
25. Geng Y.-J., Wu Q., Muszynski M. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with IFNγ, TNFα, and IL-1β Arterioscler. Thromb. Vasc. Biol. 16:1996;19.
26. Dimmeler S., Haendeler J., Galle J. Oxidized low density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. Circulation. 95:1997;1760.
27. Seelos C., Gmeiner B., Kapiotis S. Oxidized low density lipoprotein triggers programmed death of endothelial cells. Biochem. Mol. Biol. Int. 42:1997;1015.
28. Harada-Shiba M., Kinoshita M., Kamido H. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J. Biol. Chem. 273:1998;9681.
29. Hara H., Friedlander R. M., Gagliardini V. Inhibition of Il-1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA. 94:1997;2007.
30. Lizard G., Moisant M., Cor delet C. Induction of similar features of apoptosis in human and bovine vascular endothelial cells treated by 7-ketocholesterol. J. Pathol. 183:1997;330.